help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Naranda, T.
Right arrow Articles by Olsson, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Naranda, T.
Right arrow Articles by Olsson, L.
Endocrinology Vol. 143, No. 6 2293-2302
Copyright © 2002 by The Endocrine Society


RECEPTORS

Activation of Erythropoietin Receptor through a Novel Extracellular Binding Site

Tatjana Naranda, R. Ilene Kaufman, Jin Li, Kenneth Wong, Annegret Boge, Dan Hallén, Kim Y. C. Fung, Mark W. Duncan, Niels Andersen, Avram Goldstein and Lennart Olsson

Receptron, Inc. (T.N., R.I.K., J.L., K.W., A.B., L.O.), Mountain View, California 94043; Biovitrum, previously a Division of Pharmacia Corporation (D.H.), SE11276 Stockholm, Sweden; Department of Pharmaceutical Sciences (K.Y.C.F., M.W.D.), University of Colorado Health Sciences Center, Denver, Colorado 80262; Department of Chemistry (N.A.), University of Washington, Seattle, Washington 98195; and Stanford University (A.G.), Stanford, California 95305

Address all correspondence and requests for reprints to: Lennart Olsson, Receptron, Inc., 835 Maude Avenue, Mountain View, California 94043. E-mail: . lolsson{at}mcimail.com

Activation of erythropoietin (EPO) receptor (EPOR) by a small peptide (ERP) was reported previously. ERP binds to a different receptor site than EPO, and binding of ERP does not change the dissociation constant and maximal binding for EPO binding to the receptor. The extracellular binding site for ERP is now characterized. The site is located in the membrane proximal, extracellular part of the receptor. ERP binds to a region on the EPOR that contains the same sequence as ERP. It is speculated that ERP binds to its identical sequence on EPOR, as ERP self-interacts. ERP is specific for EPOR and associates noncovalently with EPOR in a ratio 1:1. Peptide binding to the receptor results in receptor-mediated cellular proliferation, intracellular signaling, and erythroid colony-forming unit formation in bone marrow cells. The activity is comparable to that of EPO. Recognition of such receptor sites represents a new and important concept in receptor function.




This article has been cited by other articles:


Home page
Sci SignalHome page
R. M. Stroud and J. A. Wells
Mechanistic Diversity of Cytokine Receptor Signaling Across Cell Membranes
Sci. Signal., May 4, 2004; 2004(231): re7 - re7.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2002 by The Endocrine Society